Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current ONTX market cap is 20.9M. The company's latest EPS is USD -0.9021 and P/E is -5.03.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 57k | 57k | 56k | 56k | 57k |
| Operating Income | -4.61M | -5.09M | -4.46M | -5.21M | -123.35M |
| Net Income | -4.25M | -4.74M | -4.18M | -4.98M | -123.14M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 2.18M | 231k | 226k | 226k | 226k |
| Operating Income | -21.7M | -24.99M | -16.5M | -19.63M | -20.3M |
| Net Income | -21.5M | -25.16M | -16.16M | -18.96M | -18.95M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 30.47M | 27.04M | 22.68M | 18.17M | 18.69M |
| Total Liabilities | 11.57M | 12.52M | 12.01M | 12.16M | 12.59M |
| Total Equity | 18.9M | 14.52M | 10.67M | 6.02M | -105.52M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 23.67M | 19.99M | 55.48M | 39.37M | 22.68M |
| Total Liabilities | 12.1M | 13.81M | 9.36M | 11.06M | 12.01M |
| Total Equity | 11.57M | 6.18M | 46.12M | 28.31M | 10.67M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -9.03M | -13.5M | -17.93M | -4.42M | -14.28M |
| Investing | N/A | -14k | -14k | N/A | -3.65M |
| Financing | N/A | N/A | N/A | N/A | 14M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -20.83M | -23.08M | -19.49M | -16.29M | -17.93M |
| Investing | -55k | -15k | N/A | N/A | -14k |
| Financing | 26.65M | 19.36M | 55.56M | N/A | N/A |
| Market Cap | 20.9M |
| Price to Earnings Ratio | -5.03 |
| Price to Sales Ratio | 420.37 |
| Price to Cash Ratio | 4.58 |
| Price to Book Ratio | 8.94 |
| Dividend Yield | - |
| Shares Outstanding | 21M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.05 (4.76%) |
| Company Name | Onconova Therapeutics Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.onconova.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
